152 related articles for article (PubMed ID: 30985721)
21. Drug-induced eosinophilic pneumonia with pulmonary alveolar hemorrhage caused by benzbromarone.
Hara A; Mukae H; Hara S; Amenomori M; Ishimoto H; Kakugawa T; Fujita H; Sakamoto N; Ishii H; Ishimatsu Y; Kohno S
Intern Med; 2010; 49(5):435-8. PubMed ID: 20190479
[TBL] [Abstract][Full Text] [Related]
22. [Impact of serum uric acid level on the cardiovascular system as a risk factor].
Hisatome I
Nihon Yakurigaku Zasshi; 2010 Dec; 136(6):325-9. PubMed ID: 21139282
[No Abstract] [Full Text] [Related]
23. Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study.
Chou HW; Chiu HT; Tsai CW; Ting IW; Yeh HC; Huang HC; Kuo CC;
Nephrol Dial Transplant; 2018 Sep; 33(9):1620-1627. PubMed ID: 29165620
[TBL] [Abstract][Full Text] [Related]
24. Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study.
Hosoya T; Sano T; Sasaki T; Fushimi M; Ohashi T
Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):62-70. PubMed ID: 31980978
[TBL] [Abstract][Full Text] [Related]
25. Renal handling of urate in a patient with familial juvenile gouty nephropathy.
Hisatome I; Kosaka H; Ohtahara K; Tsuboi M; Manabe I; Ohtahara A; Sawaguchi M; Igawa O; Tanaka Y; Fujimoto Y; Yoshida A; Takeda A; Shigemasa C
Intern Med; 1996 Jul; 35(7):564-8. PubMed ID: 8842764
[TBL] [Abstract][Full Text] [Related]
26. Rasburicase for hyperuricemia in hemolytic uremic syndrome.
Acosta AA; Hogg RJ
Pediatr Nephrol; 2012 Feb; 27(2):325-9. PubMed ID: 22089328
[TBL] [Abstract][Full Text] [Related]
27. The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand.
Stamp LK; Haslett J; Frampton C; White D; Gardner D; Stebbings S; Taylor G; Grainger R; Kumar R; Kumar S; Kain T; Porter D; Corkill M; Cathro A; Metcalfe S; Wyeth J; Dalbeth N
Intern Med J; 2016 Sep; 46(9):1075-80. PubMed ID: 27391386
[TBL] [Abstract][Full Text] [Related]
28. Benzbromarone in the treatment of gout.
Azevedo VF; Kos IA; Vargas-Santos AB; da Rocha Castelar Pinheiro G; Dos Santos Paiva E
Adv Rheumatol; 2019 Aug; 59(1):37. PubMed ID: 31391099
[TBL] [Abstract][Full Text] [Related]
29. Use of uric acid-lowering agents limits experimental cyclosporine nephropathy.
Mazali FC; Johnson RJ; Mazzali M
Nephron Exp Nephrol; 2012; 120(1):e12-9. PubMed ID: 22126908
[TBL] [Abstract][Full Text] [Related]
30. Influence of urate-lowering therapies on renal handling of uric acid.
Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
[TBL] [Abstract][Full Text] [Related]
31. Effective uric acid-lowering treatment for hypertensive patients with hyperuricemia.
Ohta Y; Ishizuka A; Arima H; Hayashi S; Iwashima Y; Kishida M; Yoshihara F; Nakamura S; Kawano Y
Hypertens Res; 2017 Mar; 40(3):259-263. PubMed ID: 27760998
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.
Perez-Ruiz F; Alonso-Ruiz A; Calabozo M; Herrero-Beites A; García-Erauskin G; Ruiz-Lucea E
Ann Rheum Dis; 1998 Sep; 57(9):545-9. PubMed ID: 9849314
[TBL] [Abstract][Full Text] [Related]
33. Urate Transporter URAT1 in Hyperuricemia: New Insights from Hyperuricemic Models.
Li X; Yan Z; Tian J; Zhang X; Han H; Ye F
Ann Clin Lab Sci; 2019 Nov; 49(6):756-762. PubMed ID: 31882426
[TBL] [Abstract][Full Text] [Related]
34. [Anti hyperuricemic agents].
Ogino K; Hisatome I; Shigemasa C
Nihon Rinsho; 2003 Jan; 61 Suppl 1():197-201. PubMed ID: 12629717
[No Abstract] [Full Text] [Related]
35. Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.
Ahn SO; Ohtomo S; Kiyokawa J; Nakagawa T; Yamane M; Lee KJ; Kim KH; Kim BH; Tanaka J; Kawabe Y; Horiba N
J Pharmacol Exp Ther; 2016 Apr; 357(1):157-66. PubMed ID: 26907620
[TBL] [Abstract][Full Text] [Related]
36. Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia.
Kuriyama S
Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):1-5. PubMed ID: 31754883
[TBL] [Abstract][Full Text] [Related]
37. [RASBURICASE TREATMENT FOR NEONATAL ACUTE KIDNEY INJURY - A CASE REPORT].
Shasha-Lavsky H; Awadia P; Sheffer V; Weissman I
Harefuah; 2021 Dec; 160(12):806-809. PubMed ID: 34957716
[TBL] [Abstract][Full Text] [Related]
38. [A case of fulminant hepatitis, possibly caused by benzbromarone].
Suzuki T; Suzuki T; Kimura M; Shinoda M; Fujita T; Miyake N; Yamamoto S; Tashiro K
Nihon Shokakibyo Gakkai Zasshi; 2001 Apr; 98(4):421-5. PubMed ID: 11400273
[No Abstract] [Full Text] [Related]
39. Benzbromarone: a double-edged sword that cuts the liver?
Haring B; Kudlich T; Rauthe S; Melcher R; Geier A
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):119-21. PubMed ID: 23196726
[No Abstract] [Full Text] [Related]
40. Excellent response to the clinical treatment of tophaceous gout.
Caldas CA; Fuller R
Clin Rheumatol; 2007 Sep; 26(9):1553-5. PubMed ID: 17047891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
